ASCEND BY NTHRYS
Research Abroad Products

Biomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 13–24 of 200 project topics
Disease-Specific Target Database with Real-Time Therapeutic Relevance Scoring
This proprietary database aggregates genomic, transcriptomic, and clinical data to rank drug targets by disease relevance and druggability potential. Subscribers access continuously updated intelligence on 10,000+ validated targets across oncology, immunology, and rare diseases, reducing R&D spending by enabling smarter target selection.
Biomics Drug Target Discovery Service Platforms Click to view more details →
CRISPR-Based Functional Genomics Screening as Outsourced Service
A full-service CRISPR screening platform that performs genome-wide or focused knockout studies to identify and validate disease-relevant targets in client-specified cell types. Pharma and biotech companies pay per-screen with tiered pricing, generating recurring revenue while eliminating expensive in-house screening infrastructure.
Biomics Drug Target Discovery Service Platforms Click to view more details →
Single-Cell Multi-Omics Target Discovery Platform for Precision Medicine
This integrated platform combines single-cell genomics, proteomics, and metabolomics data to identify cell-type-specific targets in heterogeneous tissues and tumors. Enterprise customers unlock patient-stratification biomarkers and personalized target strategies, opening premium pricing tiers and companion diagnostic opportunities.
Biomics Drug Target Discovery Service Platforms Click to view more details →
Ligand-Binding Prediction and Chemical Space Exploration SaaS Tool
A computational chemistry platform that predicts ligand-target binding affinities and maps chemical space around validated targets using deep learning models. Drug discovery teams reduce compound library sizes by 40% and accelerate lead optimization, translating to faster progression and lower synthesis costs.
Biomics Drug Target Discovery Service Platforms Click to view more details →
Target Tractability Assessment and Druggability Index Commercial Service
This decision-support service evaluates targets against proprietary druggability criteria including binding pocket structure, expression patterns, and historical drug success rates. Companies pay for assessments that derisk target selection before committing millions to chemistry optimization, improving portfolio success rates.
Biomics Drug Target Discovery Service Platforms Click to view more details →
Biomarker and Target Co-Discovery Platform for Precision Oncology
An integrated service that simultaneously identifies actionable cancer targets and patient selection biomarkers from tumor genomics and clinical data. Oncology-focused pharma and diagnostics companies monetize through dual revenue streams: target licensing plus biomarker-driven patient enrichment contracts.
Biomics Drug Target Discovery Service Platforms Click to view more details →
Target Repositioning Intelligence Platform Using Real-World Evidence
This commercial platform mines electronic health records, clinical trial data, and scientific literature to uncover novel indications for existing drug targets. Clients identify fast-track repositioning opportunities with proven safety profiles, reducing development costs by 50% and time-to-market by 3-5 years.
Biomics Drug Target Discovery Service Platforms Click to view more details →
Phenotypic Screening-to-Target Deconvolution Service with AI Integration
A specialized outsourced service that performs phenotypic compound screening followed by AI-powered target deconvolution to identify relevant targets beyond obvious pathways. Pharma clients discover unexpected targets with novel mechanisms, creating differentiated pipeline assets and potential first-in-class opportunities worth billions.
Biomics Drug Target Discovery Service Platforms Click to view more details →
AI-Powered Protein Biomarker Detection SaaS Platform
Cloud-based platform leveraging machine learning to identify and validate novel protein biomarkers from patient samples in real-time. Delivers recurring revenue through subscription tiers while reducing biomarker discovery timelines from years to months for pharma and diagnostics clients.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
High-Throughput Genomic Biomarker Screening Commercial Service
Laboratory service offering rapid sequencing and bioinformatic analysis of genetic biomarkers for drug response prediction and disease stratification. Generates revenue through per-sample processing fees and tiered contracts with biotech firms and clinical laboratories seeking scalable screening capabilities.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Metabolomic Biomarker Discovery Platform for Drug Development
Integrated software and instrumentation solution that identifies metabolic signatures associated with disease progression and drug efficacy using advanced mass spectrometry. Creates multiple revenue streams through equipment licensing, software subscriptions, and data analytics services for pharmaceutical development pipelines.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Real-Time Liquid Biopsy Analysis Dashboard and Tools
Enterprise software platform that processes and interprets circulating biomarkers from blood samples for early disease detection and treatment monitoring. Drives revenue through clinical laboratory partnerships, healthcare provider licensing, and integration fees within existing diagnostic networks.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →